Why is Maitreya Medica. falling/rising?

As of 22-Sep, Maitreya Medicare Ltd's stock price is currently at 246.95, showing no change (0.00%). The stock has outperformed its sector today by 0.43%, although it is higher than the 5-day moving averages but lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has increased by 2.98%, but it has seen a decline of 1.22% over the past month and a significant drop of 26.54% year-to-date. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.2. However, the stock's performance is negatively impacted by a substantial decline in profits, which have fallen by 40%, and a poor long-term growth outlook, with operating profit decreasing at an annual rate of 22.52% over the last five years.
In the broader market context, Maitreya Medicare Ltd's recent performance contrasts with the Sensex, which has increased by 0.53% over the past week and 1.34% over the past month. While the stock has outperformed its sector in the short term, its year-over-year return of -34.50% starkly contrasts with the Sensex's decline of only 2.28%. Additionally, the stock has experienced a significant drop in investor participation, with delivery volume falling by 52.38% against the 5-day average, indicating a lack of confidence among investors. Overall, despite some positive factors, the combination of declining profits and poor long-term growth prospects suggests that the stock is facing significant challenges.